Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Sildenafil and antidepressants improve premature ejaculation

Oct. 7, 2004

Single oral doses of palosuran are reported safe in healthy volunteers

Oct. 5, 2004

Phase IIa study of BXL-628 for BPH meets primary endpoint

Sep. 29, 2004

New approvals for tamsulosin formulations

Sep. 27, 2004

GSK researchers describe new SGK-1 inhibitors and their use

Sep. 23, 2004

Bayer patent covers new PGI2 antagonists for urological disorders and other uses

Sep. 17, 2004

Yentreve launched in Europe

Sep. 15, 2004

Ranbaxy researchers present novel muscarinic antagonists

Sep. 15, 2004

Positive one-year data for NX-1207 in BPH

Sep. 13, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...